Market Updates

Maypro Announces Distribution Partnership with Tradichem Group

Maypro will distribute Clonapure creatine complex and Hipering, a patented granulation delivery technology, in the North American market.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Алексей Коза | Adobe Stock

Maypro has announced that it has entered into a distribution partnership with Tradichem Group and its subsidiaries, Florida Human Nutrition and Tradichem Industrial Services. Maypro will now be the North American distributor of Clonapure, a fast-acting creatine complex, and Hipering, a patented granulation delivery technology.

Clonapure combines creatine monohydrate, phosphocreatine, and phosphate in ratios to optimize intracellular creatine replenishment, enhance ATP production, and support energy, power, and endurance.

Clonapure was found in a recent clinical study to deliver both immediate and long-term benefits for elite athletes, including measurable improvements in power output, endurance, and fatigue reduction during high-intensity activity.

“Creatine is experiencing remarkable growth beyond traditional sports nutrition, with increasing adoption in men’s and women’s health, active lifestyle, and metabolic support categories,” said Abhijit Natu, vice president of sales and marketing at Maypro. “Clonapure represents the next evolution in creatine supplementation; its fast-acting, clinically validated formulation not only enhances muscle performance and recovery but also addresses the needs of a wider range of consumers, including those on weight management protocols like semaglutide. With its superior absorption and targeted intracellular support, Clonapure offers brands a unique opportunity to deliver meaningful, science-backed benefits across diverse consumer segments.”

Hipering technology can transform fine powders, which are often prone to machine adhesion and poor flowability, into free-flowing, compressible granules.

This process eliminates the need for synthetic binders, fillers, or excipients, enabling cleaner label formulations and improved tablet quality.

“Hipering modifies the physical properties of raw ingredients while maintaining purity and chemical integrity,” said José Angel Maroñon, CEO of Tradichem Group. “Manufacturers can now achieve optimal production efficiency and product consistency without compromising on ingredient quality. Raw ingredients are transformed into a free-flowing, compressible form without the need for synthetic binders, fillers, or other excipients,” he explained.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters